Patents by Inventor Hea Jung Joung

Hea Jung Joung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6808703
    Abstract: The present invention relates to microorganisms for the treatment or the prevention of obesity or diabetes mellitus, which reduce the amount of monosaccharide or disaccharide which may be absorbed into human body by converting monosaccharides such as glucose, fructose, galactose et al. and disaccharides into polymeric materials which cannot be absorbed by the intestine, and relates to a pharmaceutical composition containing the said microorganisms. Preferred microorganisms are Lactobacillus sp. BC-Y009 and Acetobacter sp. BC-Y058.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: October 26, 2004
    Assignee: Bioneer Corporation
    Inventors: Han Oh Park, Young Bae Bang, Hea Jung Joung, Bong Cheol Kim, Hang Rae Kim
  • Publication number: 20030180273
    Abstract: The present invention relates to microorganisms for the treatment or the prevention of obesity or diabetes mellitus, which reduce the amount of monosaccharide or disaccharide which may be absorbed into human body by converting monosaccharides such as glucose, fructose, galactose et al. and disaccharides into polymeric materials which cannot be absorbed by the intestine, and relates to a pharmaceutical composition containing the said microorganisms.
    Type: Application
    Filed: February 3, 2003
    Publication date: September 25, 2003
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Young Bae Bang, Hea Jung Joung, Bong Cheol Kim, Hang Rae Kim
  • Publication number: 20030180271
    Abstract: The present invention relates to microorganisms for the treatment or the prevention of obesity or diabetes mellitus, which reduce the amount of monosaccharide or disaccharide which may be absorbed into human body by converting monosaccharides such as glucose, fructose, galactose et al. and disaccharides into polymeric materials which cannot be absorbed by the intestine, and relates to a pharmaceutical composition containing the said microorganisms.
    Type: Application
    Filed: February 3, 2003
    Publication date: September 25, 2003
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh Park, Young Bae Bang, Hea Jung Joung, Bong Cheol Kim, Hang Rae Kim
  • Publication number: 20020037577
    Abstract: The present invention relates to microorganisms for the treatment or the prevention of obesity or diabetes mellitus, which reduce the amount of monosaccharide or disaccharide which may be absorbed into human body by converting monosaccharides such as glucose, fructose, galactose et al. and disaccharides into polymeric materials which cannot be absorbed by the intestine, and relates to a pharmaceutical composition containing the said microorganisms.
    Type: Application
    Filed: May 16, 2001
    Publication date: March 28, 2002
    Inventors: Han Oh Park, Young Bae Bang, Hea Jung Joung, Bong Cheol Kim, Hang Rae Kim